U S PHYSICAL THERAPY INC /NV Financials
Quarterly XBRL submissions from SEC 10-K and 10-Q filings.
Income Statement (Last 8 Quarters)
(3)| Period | Revenue | YoY % | Net Income | YoY % | Operating Income | EPS |
|---|---|---|---|---|---|---|
| Q3 FY202510-Q · 2025-09-30 | $197.1M | — | $13.1M | — | $25.3M | $0.48 |
| Q2 FY202510-Q · 2025-06-30 | $164.2M | — | $0 | — | $24.9M | $0.58 |
| Q1 FY202510-Q · 2025-03-31 | $31.2M | — | $9.9M | — | $19.6M | $0.80 |
Balance Sheet
| Period | Total Assets | Total Liabilities | Cash & Equivalents | Shareholders Equity |
|---|---|---|---|---|
| Q3 FY202510-Q | $1.2B | $413.8M | $31.1M | $503.6M |
| Q2 FY202510-Q | $242.1M | $38.1M | $34.1M | $500.8M |
| Q1 FY202510-Q | $1.2B | $420.7M | $39.2M | $497.3M |
Cash Flow Highlights
| Period | Operating Income | Net Income | Gross Profit | Shares Outstanding |
|---|---|---|---|---|
| Q3 FY202510-Q | $25.3M | $13.1M | $36.9M | — |
| Q2 FY202510-Q | $24.9M | $0 | $35.2M | — |
| Q1 FY202510-Q | $19.6M | $9.9M | $25.5M | — |
Filings
(4)Methodology
Every figure on this page is pulled directly from U S PHYSICAL THERAPY INC /NV's own XBRL submissions to the U.S. Securities and Exchange Commission. XBRL is the standardized tagging format the SEC requires for line items in 10-K and 10-Q filings, which means revenue, net income, and balance-sheet entries are reported by the company itself — not estimated by us.
Cayman Journal reconciles preferred GAAP tags (for example, Revenues, RevenueFromContractWithCustomerExcludingAssessedTax) and normalizes them so quarter-over-quarter comparability is preserved. Our automated ingestion runs nightly; markets editors spot-check flagged anomalies before they appear on the public hub. Where a tag is missing for a given period, we surface an em dash rather than impute a value.
Source documents are linked under Filings above and point to the original EDGAR submission index. Errors should be reported to [email protected].